α-Enolase: a promising therapeutic and diagnostic tumor target
- PMID: 21261815
- DOI: 10.1111/j.1742-4658.2011.08025.x
α-Enolase: a promising therapeutic and diagnostic tumor target
Abstract
α-enolase (ENOA) is a metabolic enzyme involved in the synthesis of pyruvate. It also acts as a plasminogen receptor and thus mediates activation of plasmin and extracellular matrix degradation. In tumor cells, ΕΝΟΑ is upregulated and supports anaerobic proliferation (Warburg effect), it is expressed at the cell surface, where it promotes cancer invasion, and is subjected to a specific array of post-translational modifications, namely acetylation, methylation and phosphorylation. Both ENOA overexpression and its post-translational modifications could be of diagnostic and prognostic value in cancer. This review will discuss recent information on the biochemical, proteomics and immunological characterization of ENOA, particularly its ability to trigger a specific humoral and cellular immune response. In our opinion, this information can pave the way for effective new therapeutic and diagnostic strategies to counteract the growth of the most aggressive human disease.
© 2011 The Authors Journal compilation © 2011 FEBS.
Similar articles
-
Alpha-Enolase (ENO1), a potential target in novel immunotherapies.Front Biosci (Landmark Ed). 2017 Jan 1;22(5):944-959. doi: 10.2741/4526. Front Biosci (Landmark Ed). 2017. PMID: 27814656 Review.
-
Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells.J Proteome Res. 2010 Jun 4;9(6):2929-36. doi: 10.1021/pr901109w. J Proteome Res. 2010. PMID: 20433201
-
Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancer.J Proteome Res. 2011 Jan 7;10(1):105-12. doi: 10.1021/pr100213b. Epub 2010 Jun 10. J Proteome Res. 2011. PMID: 20455595
-
Surface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target.PLoS One. 2013 Jul 19;8(7):e69354. doi: 10.1371/journal.pone.0069354. Print 2013. PLoS One. 2013. PMID: 23894455 Free PMC article.
-
α-Enolase, a multifunctional protein: its role on pathophysiological situations.J Biomed Biotechnol. 2012;2012:156795. doi: 10.1155/2012/156795. Epub 2012 Oct 14. J Biomed Biotechnol. 2012. PMID: 23118496 Free PMC article. Review.
Cited by
-
Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunoprevention.Clin Cancer Res. 2015 Apr 1;21(7):1549-57. doi: 10.1158/1078-0432.CCR-14-1186. Epub 2015 Jan 26. Clin Cancer Res. 2015. PMID: 25623216 Free PMC article. Review.
-
Alpha-enolase is upregulated on the cell surface and responds to plasminogen activation in mice expressing a ∆133p53α mimic.PLoS One. 2015 Feb 2;10(2):e0116270. doi: 10.1371/journal.pone.0116270. eCollection 2015. PLoS One. 2015. PMID: 25643152 Free PMC article.
-
Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.Mol Cell Proteomics. 2016 Dec;15(12):3564-3580. doi: 10.1074/mcp.M116.060244. Epub 2016 Oct 14. Mol Cell Proteomics. 2016. PMID: 27742740 Free PMC article.
-
Novel ginsenoside derivative 20(S)-Rh2E2 suppresses tumor growth and metastasis in vivo and in vitro via intervention of cancer cell energy metabolism.Cell Death Dis. 2020 Aug 14;11(8):621. doi: 10.1038/s41419-020-02881-4. Cell Death Dis. 2020. PMID: 32796841 Free PMC article.
-
Chemotherapy Resistance in Advanced Ovarian Cancer Patients.Biomark Cancer. 2019 Jul 5;11:1179299X19860815. doi: 10.1177/1179299X19860815. eCollection 2019. Biomark Cancer. 2019. PMID: 31308780 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources